114 related articles for article (PubMed ID: 38518721)
1. NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma.
Hu S; Yuan Y; Yan R; Xie H; Cai R; Xu J
Biochem Biophys Res Commun; 2024 May; 708():149798. PubMed ID: 38518721
[TBL] [Abstract][Full Text] [Related]
2. Histone lysine methyltransferase SETDB2 suppresses NRF2 to restrict tumor progression and modulates chemotherapy sensitivity in lung adenocarcinoma.
Yuan G; Hu B; Ma J; Zhang C; Xie H; Wei T; Yang Y; Ni B
Cancer Med; 2023 Mar; 12(6):7258-7272. PubMed ID: 36504353
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor Nrf2 binds to circRNAPIBF1 to regulate SOD2 in lung adenocarcinoma progression.
Zhang Z; Chen Q; Huang C; Rao D; Sang C; Zhu S; Gu L; Xie C; Tang Z; Xu X
Mol Carcinog; 2022 Dec; 61(12):1161-1176. PubMed ID: 36193777
[TBL] [Abstract][Full Text] [Related]
4. TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway.
Yu B; Zhou Y; He J
Cell Cycle; 2023 Jun; 22(12):1496-1513. PubMed ID: 37245083
[TBL] [Abstract][Full Text] [Related]
5. Non-canonical regulation of the reactivation of an oncogenic herpesvirus by the OTUD4-USP7 deubiquitinases.
Wang S; Tian X; Zhou Y; Xie J; Gao M; Zhong Y; Zhang C; Yu K; Bai L; Qin Q; Zhong B; Lin D; Feng P; Lan K; Zhang J
PLoS Pathog; 2024 Jan; 20(1):e1011943. PubMed ID: 38215174
[TBL] [Abstract][Full Text] [Related]
6. Mild Oxidative Stress Reduces NRF2 SUMOylation to Promote
Xu J; Guo H; Xing Z; Zhang W; He J; Cheng J; Cai R
Oxid Med Cell Longev; 2020; 2020():6240125. PubMed ID: 33299528
[TBL] [Abstract][Full Text] [Related]
7. Exo-miR-1290-induced by COX-2 overexpression promotes cancer-associated fibroblasts activation and tumor progression by CUL3-Nrf2 pathway in lung adenocarcinoma.
Bai X; Shao J; Duan T; Liu X; Wang M; Li X; You Q; Zhang Z; Pan J
Cell Commun Signal; 2023 Sep; 21(1):242. PubMed ID: 37723559
[TBL] [Abstract][Full Text] [Related]
8. Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS.
Liuyu T; Yu K; Ye L; Zhang Z; Zhang M; Ren Y; Cai Z; Zhu Q; Lin D; Zhong B
Cell Res; 2019 Jan; 29(1):67-79. PubMed ID: 30410068
[TBL] [Abstract][Full Text] [Related]
9. OTUD4 Is a Phospho-Activated K63 Deubiquitinase that Regulates MyD88-Dependent Signaling.
Zhao Y; Mudge MC; Soll JM; Rodrigues RB; Byrum AK; Schwarzkopf EA; Bradstreet TR; Gygi SP; Edelson BT; Mosammaparast N
Mol Cell; 2018 Feb; 69(3):505-516.e5. PubMed ID: 29395066
[TBL] [Abstract][Full Text] [Related]
10. LncRNA UCA1 promoted cisplatin resistance in lung adenocarcinoma with HO1 targets NRF2/HO1 pathway.
Shi W; Ling L; Li C; Wu R; Zhang M; Shao F; Wang Y
J Cancer Res Clin Oncol; 2023 Mar; 149(3):1295-1311. PubMed ID: 35792913
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma.
Zhang T; Su F; Wang B; Liu L; Lu Y; Su H; Ling R; Yue P; Dai H; Yang T; Yang J; Chen R; Wu R; Zhu K; Zhao D; Hou X
Oncogene; 2024 Apr; 43(16):1190-1202. PubMed ID: 38409551
[TBL] [Abstract][Full Text] [Related]
12. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract][Full Text] [Related]
13. [Role of the expression level of Nrf2 in predicting response of EGFR-TKIs in lung adenocarcinoma patients with EGFR gene mutations].
Zhu X; Liang L; Liu C; Yin W; Chen S; Cao B
Zhongguo Fei Ai Za Zhi; 2014 Feb; 17(2):155-62. PubMed ID: 24581168
[TBL] [Abstract][Full Text] [Related]
14. [Nrf2 and Keap1 Abnormalities in 104 Lung Adenocarcinoma Cases and Association with Clinicopathologic Features].
Xiao Y; Zhu X; Gu Y; Chen S; Liang L; Cao B
Zhongguo Fei Ai Za Zhi; 2018 Mar; 21(3):241-250. PubMed ID: 29587953
[TBL] [Abstract][Full Text] [Related]
15. CHML is an NRF2 target gene that regulates mTOR function.
Dodson M; Dai W; Anandhan A; Schmidlin CJ; Liu P; Wilson NC; Wei Y; Kitamura N; Galligan JJ; Ooi A; Chapman E; Zhang DD
Mol Oncol; 2022 Apr; 16(8):1714-1727. PubMed ID: 35184380
[TBL] [Abstract][Full Text] [Related]
16. Investigating the functional role of SETD6 in lung adenocarcinoma.
Xu J; Zhou H; Luo Z; Chen J; Liu M
BMC Cancer; 2023 Jan; 23(1):18. PubMed ID: 36604642
[TBL] [Abstract][Full Text] [Related]
17. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma.
Sakurai T; Isogaya K; Sakai S; Morikawa M; Morishita Y; Ehata S; Miyazono K; Koinuma D
Oncogene; 2016 Sep; 35(38):5000-9. PubMed ID: 26923328
[TBL] [Abstract][Full Text] [Related]
18. USP15 negatively regulates Nrf2 through deubiquitination of Keap1.
Villeneuve NF; Tian W; Wu T; Sun Z; Lau A; Chapman E; Fang D; Zhang DD
Mol Cell; 2013 Jul; 51(1):68-79. PubMed ID: 23727018
[TBL] [Abstract][Full Text] [Related]
19. OTUD4 enhances TGFβ signalling through regulation of the TGFβ receptor complex.
Jaynes PW; Iyengar PV; Lui SKL; Tan TZ; Vasilevski N; Wright SCE; Verdile G; Jeyasekharan AD; Eichhorn PJA
Sci Rep; 2020 Sep; 10(1):15725. PubMed ID: 32973272
[TBL] [Abstract][Full Text] [Related]
20. CSE reduces OTUD4 triggering lung epithelial cell apoptosis via PAI-1 degradation.
Luo L; Li T; Zeng Z; Li H; He X; Chen Y
Cell Death Dis; 2023 Sep; 14(9):614. PubMed ID: 37726265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
